Transarterial chemoembolization plus stent placement for hepatocellular carcinoma with main portal vein tumor thrombosis: A meta-analysis

doi:10.5306/wjco.v15.i3.447

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 15, Issue 3

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (1600)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-7) series, Tables (1-1) series.

Item

Count

PDF

HTML

796

Figures (1-7)

171

Tables (1-1)

210

Sum=1223

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

101

Download

220

Sum=321

Mar 24, 2024 (publication date) through Dec 23, 2024

Times Cited of This Article

Times Cited (0)

Journal Information of This Article

Publication Name

World Journal of Clinical Oncology

ISSN

2218-4333

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Meta-Analysis

World J Clin Oncol. Mar 24, 2024; 15(3): 447-455
Published online Mar 24, 2024. doi: 10.5306/wjco.v15.i3.447

Transarterial chemoembolization plus stent placement for hepatocellular carcinoma with main portal vein tumor thrombosis: A meta-analysis

Wei-Fan Sui, Jian-Yun Li, Jian-Hua Fu

Wei-Fan Sui, Jian-Yun Li, Jian-Hua Fu, Department of Interventional Radiology, Zhenjiang First People's Hospital, Zhenjiang 212000, Jiangsu Province, China

Author contributions: Fu JH designed the research study; Li JY and Sui WF performed the research; Sui WF analyzed the data and wrote the manuscript; all authors have read and approved the final manuscript.

Conflict-of-interest statement: All the authors report no relevant conflicts of interest for this article.

PRISMA 2009 Checklist statement: The authors have read the PRISMA 2009 Checklist, and the manuscript was prepared and revised according to the PRISMA 2009 Checklist.

Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/

Corresponding author: Jian-Hua Fu, Doctor, Director, Department of Interventional Radiology, Zhenjiang First People’s Hospital, No. 8 Dianli Road, Zhenjiang 212000, Jiangsu Province, China. suiweifan@126.com

Received: October 29, 2023
Peer-review started: October 29, 2023
First decision: December 22, 2023
Revised: January 5, 2024
Accepted: February 4, 2024
Article in press: February 4, 2024
Published online: March 24, 2024
Processing time: 145 Days and 9.8 Hours

Core Tip

Core Tip: Portal vein tumor thrombus (PVTT) as an important indicator of poor prognosis existed in 44% of patients with hepatocellular carcinoma (HCC). Transarterial chemoembolization (TACE) is recommended as the standard first-line therapy in unresectable hepatocellular carcinoma. Some Chinese scholars have found that TACE combined with portal vein stent placement is safe and could prolong the survival time in HCC patients with PVTT.